Neurogene (NGNE) EPS (Basic) (2013 - 2026)
Neurogene's (NGNE) quarterly EPS (Basic) came in at -$1.72 in Q1 2026, down 53.93% YoY from -$3.73 in Q1 2025, and down 45.95% on a QoQ basis from -$1.18 in Q4 2025.
Neurogene (NGNE) EPS (Basic) (2013 - 2026) Analysis & Trends
Neurogene (NGNE) has 14 years of EPS (Basic) data on file, last reported at -$1.72 in Q1 2026.
- Quarterly EPS (Basic) fell 53.93% year-over-year to -$1.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.02 (up 8.02% YoY) and the FY2025 annual result came in at -$10.86, down 0.86% from the prior year.
- EPS (Basic) retreated to -$1.72 in Q1 2026, from -$1.18 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$1.1 in Q4 2024 to a low of -$28.4 in Q4 2023.
- A 5-year average of -$5.36 and a median of -$2.88 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 57.36% — and 2024, when it jumped 96.14%.
- Tracing NGNE's EPS (Basic) over 5 years: stood at -$18.05 in 2022, then sank by 57.36% to -$28.4 in 2023, then surged by 96.14% to -$1.1 in 2024, then fell by 7.36% to -$1.18 in 2025, then tumbled by 45.95% to -$1.72 in 2026.
- The last three EPS (Basic) figures came in at -$1.72 (Q1 2026), -$1.18 (Q4 2025), and -$1.13 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Neurogene | 815.03 Mn | 815.03 Mn | - | -2.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.91 |
| Mar 31, 2026 | -1.72 |
| Dec 31, 2025 | -1.18 |
| Sep 30, 2025 | -1.13 |
| Jun 30, 2025 | -1.17 |
| Mar 31, 2025 | -1.12 |
| Dec 31, 2024 | -1.10 |
| Sep 30, 2024 | -2.38 |
| Jun 30, 2024 | -1.87 |
| Mar 31, 2024 | -2.88 |
| Dec 31, 2023 | -28.40 |
| Sep 30, 2023 | -5.25 |
| Jun 30, 2023 | -4.23 |
| Mar 31, 2023 | -4.42 |
| Dec 31, 2022 | -18.05 |
| Sep 30, 2022 | -4.96 |
| Jun 30, 2022 | -5.78 |
| Mar 31, 2022 | -5.58 |
| Dec 31, 2021 | -14.67 |
| Sep 30, 2021 | -12.28 |